Michal Ainemer

Biotechnology General is a biopharmaceutical company that creates medical items for humans developed from biotechnology and genetic engineering techniques. They provide analytical methodology for both bacterially-derived and mammalian cell culture-based recombinant proteins undergoing pre-clinical and clinical studies.